NCT05586516 2026-03-30A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic CanceriOncturaPhase 1/2 Completed16 enrolled
NCT07042919 2025-06-29Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver CancerNorthwestern UniversityPhase 1/2 Not yet recruiting53 enrolled